MedTrace Logo

Comparison of the Effects of Standardized Chokeberry Extracts With Various Formulations on the Levels of Selected Markers Associated With Cardiovascular Disease

NCT05988099 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-08-23

No results posted yet for this study

Summary

The aim of the study is to compare in a clinical condition the effect of standardized chokeberry extract in different formulations and a complex preparation containing chokeberry extract and other active ingredients in on the levels of selected markers associated with cardiovascular diseases in people with a predisposition to the development of these diseases.

Conditions

Interventions

DIETARY_SUPPLEMENT

Complex product

400 mg of chokeberry extract in liposomal formulation and L-arginine, vitamin E, vitamin A, folic acid, chromium

DIETARY_SUPPLEMENT

Chokeberry extract in liposomal formulation

400 mg of chokeberry extract in liposomal formulation

DIETARY_SUPPLEMENT

Chokeberry extract in traditional formulation

400 mg of chokeberry extract in traditional formulation

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • AronPharma Sp. z o. o.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-20
Primary Completion
2023-07-28
Completion
2023-07-28

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05988099 on ClinicalTrials.gov